141 results
Page 3 of 8
8-K
EX-1.1
2aj8u
15 Sep 21
Entry into a Material Definitive Agreement
9:47pm
8-K
EX-1.1
gdn efaonwtvg7z
14 Oct 20
Entry into a Material Definitive Agreement
6:04am
424B5
foyv0ng58bw c2a
13 Oct 20
Prospectus supplement for primary offering
5:27pm
8-K
EX-99.1
5y0ekuvcswe jxerjkma
13 Jul 20
Other Events
4:13pm
S-3ASR
EX-1.2
776kvpei fi15vi0
8 Jul 20
Automatic shelf registration
8:50am
S-3ASR
b3c7yt wt81ws
8 Jul 20
Automatic shelf registration
8:50am
8-K
EX-10.1
16rkt3xy39afdtb2
15 Jun 20
Vaxart, Inc. Appoints New CEO to Accelerate Advancement of COVID-19 and Other Programs
5:25pm
8-K
EX-99.2
43nw6uf481 ut4
19 Mar 20
Vaxart Announces Fourth Quarter and Full Year 2019 Financial Results
4:04pm
8-K
EX-10.1
13qvjd7iywk6o1
2 Mar 20
Vaxart Announces $10.0 Million Registered Direct Offering Priced At-the-Market
2:48pm